Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,638 Cr
down ₹50.4 Cr vs Oct 2024
- Stocks held
- 35
- up 2 vs Oct 2024
- Top 10 weight
- 60.2%
- of the portfolio in its ten largest
- Cash & debt
- 3.1%
- cash, money market and debt
- Moves this month
- 2 in · 0 out
- added to 10, trimmed 18
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In November 2024 it disclosed 35 stocks worth ₹8,638 Cr, down ₹50.4 Cr from Oct 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.5%), Divi's Laboratories Limited (9.7%), Lupin Limited (7.6%); the ten largest together made up 60.2% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.7% of its equity. Cash and debt stood at 3.1%. Compared with Oct 2024 the fund entered 2 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
26%
Holds more stocks than 26% of peers
Cash
45%
Holds more cash than 45% of peers
Holdings in November 2024
Download CSVEvery line the fund disclosed, with the change against Oct 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.52%
- Δ weight
- down 0.43 pts
- Value
- ₹1,168 Cr
- Δ value
- down ₹44.6 Cr
- Status
- Trimmed
- Weight
- 9.65%
- Δ weight
- up 0.50 pts
- Value
- ₹834 Cr
- Δ value
- up ₹38.2 Cr
- Status
- Added
- Weight
- 7.61%
- Δ weight
- down 0.46 pts
- Value
- ₹657 Cr
- Δ value
- down ₹43.6 Cr
- Status
- Trimmed
- Weight
- 5.50%
- Δ weight
- down 0.03 pts
- Value
- ₹476 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 5.13%
- Δ weight
- down 0.11 pts
- Value
- ₹443 Cr
- Δ value
- down ₹12.6 Cr
- Status
- Trimmed
- Weight
- 5.10%
- Δ weight
- down 0.04 pts
- Value
- ₹440 Cr
- Δ value
- down ₹5.7 Cr
- Status
- Trimmed
- Weight
- 4.09%
- Δ weight
- up 0.61 pts
- Value
- ₹353 Cr
- Δ value
- up ₹50.6 Cr
- Status
- Added
- Weight
- 3.36%
- Δ weight
- down 0.03 pts
- Value
- ₹290 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 3.23%
- Δ weight
- up 0.87 pts
- Value
- ₹279 Cr
- Δ value
- up ₹73.8 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 3.07%
- Δ weight
- down 1.36 pts
- Value
- ₹266 Cr
- Δ value
- down ₹119 Cr
- Status
- Trimmed
- Weight
- 3.02%
- Δ weight
- up 0.17 pts
- Value
- ₹261 Cr
- Δ value
- up ₹13 Cr
- Status
- Added
- Weight
- 2.77%
- Δ weight
- down 0.11 pts
- Value
- ₹240 Cr
- Δ value
- down ₹10.8 Cr
- Status
- Trimmed
- Weight
- 2.67%
- Δ weight
- down 0.10 pts
- Value
- ₹230 Cr
- Δ value
- down ₹10 Cr
- Status
- Trimmed
- Weight
- 2.57%
- Δ weight
- down 0.32 pts
- Value
- ₹222 Cr
- Δ value
- down ₹28.9 Cr
- Status
- Trimmed
- Weight
- 2.49%
- Δ weight
- down 0.25 pts
- Value
- ₹215 Cr
- Δ value
- down ₹22.8 Cr
- Status
- Trimmed
- Weight
- 2.36%
- Δ weight
- down 0.24 pts
- Value
- ₹204 Cr
- Δ value
- down ₹22.3 Cr
- Status
- Trimmed
- Weight
- 2.24%
- Δ weight
- down 0.07 pts
- Value
- ₹193 Cr
- Δ value
- down ₹7.1 Cr
- Status
- Trimmed
- Weight
- 2.20%
- Δ weight
- up <0.01 pts
- Value
- ₹190 Cr
- Δ value
- down ₹92 L
- Status
- Held
- Weight
- 2.04%
- Δ weight
- up 0.14 pts
- Value
- ₹177 Cr
- Δ value
- up ₹11.5 Cr
- Status
- Added
- Weight
- 1.96%
- Δ weight
- up 0.09 pts
- Value
- ₹169 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 1.94%
- Δ weight
- up 0.08 pts
- Value
- ₹167 Cr
- Δ value
- up ₹6.1 Cr
- Status
- Added
- Weight
- 1.81%
- Δ weight
- down 0.03 pts
- Value
- ₹157 Cr
- Δ value
- down ₹3.8 Cr
- Status
- Trimmed
- Weight
- 1.76%
- Δ weight
- up 0.10 pts
- Value
- ₹152 Cr
- Δ value
- up ₹7.9 Cr
- Status
- Added
- Weight
- 1.70%
- Δ weight
- down 0.10 pts
- Value
- ₹147 Cr
- Δ value
- down ₹9.3 Cr
- Status
- Trimmed
- Weight
- 1.23%
- Δ weight
- up 0.11 pts
- Value
- ₹106 Cr
- Δ value
- up ₹9.1 Cr
- Status
- Added
- Weight
- 1.21%
- Δ weight
- up 0.16 pts
- Value
- ₹104 Cr
- Δ value
- up ₹13.6 Cr
- Status
- Added
- Weight
- 1.19%
- Δ weight
- down 0.02 pts
- Value
- ₹103 Cr
- Δ value
- down ₹2.1 Cr
- Status
- Trimmed
- Weight
- 1.01%
- Δ weight
- down 0.03 pts
- Value
- ₹86.8 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 0.69%
- Δ weight
- up 0.03 pts
- Value
- ₹59.6 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 0.52%
- Δ weight
- up 0.06 pts
- Value
- ₹45.2 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 0.49%
- Δ weight
- down 0.08 pts
- Value
- ₹42.1 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- down 0.02 pts
- Value
- ₹41 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.43%
- Δ weight
- up 0.43 pts
- Value
- ₹36.8 Cr
- Δ value
- up ₹36.8 Cr
- Status
- New
- Weight
- 0.41%
- Δ weight
- up 0.41 pts
- Value
- ₹35 Cr
- Δ value
- up ₹35 Cr
- Status
- New
- Weight
- 0.32%
- Δ weight
- up 0.03 pts
- Value
- ₹27.2 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 0.28%
- Δ weight
- up 0.04 pts
- Value
- ₹23.8 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
What changed, Oct 2024 to Nov 2024
New New positions (2)
- IPCA Laboratories Limited0.4% · ₹36.8 Cr
- Suraksha Diagnostic Limited0.4% · ₹35 Cr
Exited Exited (0)
None.
Added Biggest additions
- MedPlus Health Services Limitedup ₹73.8 Cr (+0.87% pts)
- Vijaya Diagnostic Centre Limitedup ₹50.6 Cr (+0.61% pts)
- Divi's Laboratories Limitedup ₹38.2 Cr (+0.50% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Oct 2024, the weight rose most in Healthcare Services (+1.1 pts) and Retailing (+0.9 pts), and fell most in Pharmaceuticals & Biotechnology (−2.0 pts).
- Healthcare Services18.2% → 19.3%+1.1 pts
- Retailing2.5% → 3.3%+0.9 pts
- Pharmaceuticals & Biotechnology78.7% → 76.7%−2.0 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Nov 2021 | Nov 2023 | May 2024 | Aug 2024 | Oct 2024 | Nov 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 74.9% | 76.6% | 78.2% | 79.0% | 78.7% | 76.7% |
| Healthcare Services | 22.7% | 18.2% | 17.9% | 17.7% | 18.2% | 19.3% |
| Retailing | — | 4.0% | 3.2% | 2.5% | 2.5% | 3.3% |
| Pharmaceuticals | 1.8% | 1.1% | 0.8% | 0.8% | 0.7% | 0.7% |
Allocation in Nov 2024change vs Oct 2024
- Pharmaceuticals & Biotechnology (23)76.7%▼ 2.0 pts
- Healthcare Services (10)19.3%▲ 1.1 pts
- Retailing (1)3.3%▲ 0.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Nov 2024
3.1%
▼ 1.4 pts vs Oct 2024
- Cash alone
- 3.0%
- cash and net receivables
- A year earlier
- 0.5%
- Nov 2023 · now ▲ 2.6 pts
- Last 12 months
- 0.6% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.